Trials

A first-in-human, multicenter, open-label, multiple ascending dose Phase I study in patients with advanced solid tumors to determine the safety, pharmacokinetics and pharmacodynamics of intratumorally administered ADC-1013

Cancer type: Multiple diagnosis

Phase: I

Principal Investigator: Yachnin Jeffrey

Country: SE

Keywords: Sweden, Stockholm

Status: Inclusion completed

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02379741?term=A+first-in-human%2C+multicenter%2C+open-label%2C+multiple+ascending+dose+Phase+I+study+in+patients+with+advanced+solid+tumors+to+determine+the+safety%2C+pharmacokinetics+and+pharmacodynamics+of+intratum